about
CTLA4 polymorphisms and de novo malignancy risk after renal transplantation in Chinese recipients.De novo malignancy after liver transplantation: a single-center experience of 14 cases.Everolimus: efficacy and safety in cardiac transplantation.Optimal management of skin cancer in immunosuppressed patients.Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In VivoRenal transplantation with kidneys affected by tumoursAdvanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report.
P2860
Q35033897-6718F0C5-D227-4A18-8ED3-287F5E3520EFQ35257314-EFDAE914-F439-4A5D-90FC-F3C514813476Q37779322-935004C0-3DD8-46C0-AE96-1B054E57D9A9Q38228585-AFA97628-927F-4DE9-8549-5EC879E88E79Q41285493-35D6DC84-6007-4A14-846F-A3E36618B05BQ42043813-544B33C2-4215-4A1C-BFC8-A2BDBFAE8FA8Q47547287-C7E9D25A-6A52-4ED6-82C7-A70053E6B98F
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Minimizing the risk of posttransplant malignancy.
@en
type
label
Minimizing the risk of posttransplant malignancy.
@en
prefLabel
Minimizing the risk of posttransplant malignancy.
@en
P1476
Minimizing the risk of posttransplant malignancy.
@en
P2093
J M Campistol
P356
10.1016/J.TRANSPROCEED.2008.10.015
P407
P433
P577
2008-12-01T00:00:00Z